Quadrise (LON:QED) Trading 10.2% Higher - Should You Buy?

Key Points

• Quadrise shares rose 10.2% midday to GBX 3.14 (intraday high GBX 3.40) on volume of 4,461,610 shares—slightly below the average session volume—with a prior close of GBX 2.85.
• Shore Capital Group reiterated a "house stock" rating on Jan 12; the stock has a market capitalization of £62.99 million, a negative P/E of -18.47, beta 1.09, 50-day MA GBX 2.14 and 200-day MA GBX 2.66.
• Quadrise is an AIM-listed energy technology company that licenses its proprietary MSAR® and bioMSAR™ heavy oil and synthetic biofuel technologies worldwide.

Quadrise Plc (LON:QED - Get Free Report)'s share price traded up 10.2% during mid-day trading on Wednesday . The company traded as high as GBX 3.40 and last traded at GBX 3.14. 4,461,610 shares traded hands during mid-day trading, a decline of 6% from the average session volume of 4,756,140 shares. The stock had previously closed at GBX 2.85.

Analyst Upgrades and Downgrades

Separately, Shore Capital Group restated a "house stock" rating on shares of Quadrise in a research report on Monday, January 12th.

Quadrise Trading Up 10.2%

The stock has a market capitalization of £62.99 million, a P/E ratio of -18.47 and a beta of 1.09. The company's 50-day moving average is GBX 2.14 and its two-hundred day moving average is GBX 2.66.

Quadrise Company Profile

Quadrise is a global innovator and licensor of the disruptive heavy oil and synthetic biofuel technology that produces its proprietary MSAR® and bioMSAR™ fuels. Quadrise employs a team of energy and fuel experts with extensive experience in commercial emulsion fuels, downstream, marine and power utility applications at a global level. Quadrise's shares have been listed on the London Stock Exchange's AIM market since 2006 AIM: QED.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.